EAA conventions are scheduled biannually
The EAA is planning to hold conventions with invited participants from all stakeholder groups to discuss key challenges within the European access environment.
The agenda will include both, a ‘top-down’ health policy perspective by covering key market access strategy trends as well as a ‘bottom-up’ granular HTA perspective by identifying and discussing the most heterogeneous and controversial HTA procedures across Europe.
Where feasible, conventions or individual sessions will be made accessible to a wider audience via online-streaming. Further, the proceedings of the EAA conventions will be published.
Current / Upcoming Convention
THANK YOU for joining the EAA Spring Convention 2025
'Approaching Performance Measurement for EU HTA'
Once again, we had excellent, heated and very fruitful and constructive discusssions with our experts, the German Oganising Committee and all our virtual and on-site participants.
Thanks so much to all who contributed!
Abstracts, presentations and videos are now available below and here.
We look forward to continuing the dialogue in November including a first experience exchange on JSC & JCA:
Save the Date of our Fall Convention 2025 in Paris:
November 6/7.
Recent Conventions
Video-recordings of the EAA Spring Convention, April 2025,
Approaching Performance Measurement for EU HTA
Welcome by Jürgen Wasem
(University of Duisburg-Essen) and
Jörg Ruof
(EAA Secretariat), with
Petra Nies (G-BA)
Maya Matthews
(Head of Unit at DG Santé, European Commission)
Niklas Hedberg
(Co-Chair at the Member State Coordination Group on HTA)
Rui Santos Ivo
(Chair of Heads of HTA Agencies Group (HAG), President at INFARMED)
Bruno Falissard
(Director of CESP/INSERM U1018)
Ansgar Hebborn
(Chair of the HTA Working Group at efpia, Head of European Access Policy Affairs at F. Hoffmann-La Roche AG)
Andrew Wilson
(Co-Director, Leeder Centre for Health Policy, Economics and Data, University of
Sydney, Chair, Australian HTA Review Implementation Advisory Group)
Roundtable Discussion
(J. Mosset, B. Wörmann, M. Berntgen, G. Scroccaro)
Christian Dierks
(Professor for Health Services Research, Charité Berlin, CEO at Dierks+ Company)
Video-recordings of the EAA Fall Convention, October 2024,
EU HTA: Transitioning from Preparation to Implementation - Approaching the Pain Points
Welcome by Fabrizio Gianfrate
(University of Ferrara) and Jörg Ruof (EAA Secretariat)
Dirk Van den Steen
(Deputy Head of Unit at DG Santé, European Commission)
Marco Marchetti
(Co-Chair at HTA Coordination Group)
Robert Giovanni Nisticò (President at AIFA)
Elias Pèan
(Head of Oncology and Radiopharmaceuticals, EMA)
Robin Doeswijk
(Head of European Affairs, EHA)
François Houÿez
(Director of Treatment Information and Access, EURORDIS)
Bernhard Wörmann
(Medical Superintendent at DGHO & Charité University Medicine)
Nathalie Largeron
(Global Head of HTA Strategy, Sanofi)
Panel Discussion
(E. Pèan, R. Doeswijk, F. Houÿez, B. Wörmann, N. Largeron, Video: M. Marchetti)
Video-recordings of the EAA Spring Convention, April 2024,
EU HTA - Finding the Right Balance
Maureen Rutten-van Mölken
(Head of HTA Department at ESHPM, Erasmus University)
Maya Matthews
(Head of Unit at DG Santé, European Commission)
Bernhard Wörmann
(Medical Superintendant at DGHO & Charité University Medicine)
Antonella Cardone
(CEO at Cancer Patients Europe)
Maiwenn Al
(HTA Department at ESHPM, Erasmus University)
Stefan Lange
(former Deputy Head at IQWiG)
Francesco Pignatti
(Scientific Advisor for Oncology at EMA)
Elisabeth de Vries
(Cancer Medicines Committee & MCBS Working Group at ESMO)
Laetitia Mariani
(HTA Collaborations Lead at Abbvie)
Panel Discussion
(B. Wörmann, A. Cardone, M. Al, S. Lange, F. Pignatti, E. de Vries, L. Mariani)
Carin Uyl-de Groot
(HTA Department at ESHPM, Erasmus University)
Michael Ermisch
(Head of Department AMNOG G-BA at GKV-SV)
Click here for the complete proceedings of past EAA Conventions.